Termination of liquidity agreement between TERACT and Gilbert Dupont announced, with 136,406 shares and €89,668.15 cash balance in the liquidity account. TERACT is a major distribution player in ...

DeFi Technologies to host webinar introducing DEFT Valour Investment Opportunity Index, bridging traditional capital markets ...

Gimv kondigt inkoop eigen aandelen aan in kader van aandelenaankoopplan voor raad van bestuur, executief comité en werknemers. Programma start op 20 februari 2026 ...

SFPI Group announces the Semestrial Report S2 2025 on its liquidity agreement with Gilbert Dupont stock company, revealing significant transactions and account details ...

Safran's monthly statement discloses total number of shares and voting rights as per French commercial code and AMF regulations ...

Publication mensuelle du nombre d'actions composant le capital social et du nombre total de droits de vote de SAFRAN ...

Bigben Interactive announces temporary suspension of trading in its shares and bonds on Euronext Paris and Euronext Access Paris due to financial difficulties. Company to restructure debt ...

Gimv initiates a share buyback program of 75,000 shares as part of a share purchase plan for Board members, Executives, and employees. Program runs from Feb 20 to Mar 27, 2026, managed on Euronext Bru ...

BB Biotech AG releases its 2025 annual report, reporting a strong performance with a +34.2% total return in CHF. The annual report includes detailed information on the biotechnology sector and the com ...

Marie Brizard Wine & Spirits reports FY 2025 revenues of €172.0m (-8.6% vs 2024) and Q4 2025 revenues of €44.6m (-6.9%). Global spirits market slowdown impacts sales, with French market hit by ...

Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen en specialiseert zich in farmaceutische onderaannemers ...

THX Pharma (Theranexus) announces cash position of €7.8 million as of Dec 31, 2025. Pro forma cash position reaches €21.7 million with incoming payment from Biocodex agreement. Company focused on rare ...